Klinefelter Syndrome

Test for Klinefelter syndrome in a patient with infertility, very small testes, gynecomastia, tall stature with relatively long limbs, reduced androgenic hair distribution, pubertal failure or incomplete virilization, or learning and social difficulties. Clinical phenotype is variable; in a cohort referred for suspected disease, patients with confirmed Klinefelter syndrome were taller, had smaller testes, and had higher LH and FSH values than patients with a 46,XY karyotype, while general clinical features alone did not reliably discriminate the groups. Wiley+1WileyClinical and Diagnostic Features of Patients With Suspected Klinefelter Syndrome - Kamischke - 2003 - Journal of Andrology - Wiley Online LibraryScienceDirectKlinefelter Syndrome - an overview | ScienceDirect Topics

Obtain morning total testosterone, LH, and FSH when gonadal failure is suspected. The characteristic pattern is primary testicular failure: low testosterone with elevated LH and FSH; seminiferous dysfunction may be prominent even when total testosterone remains in the low-normal range. Elevated gonadotropins with small testes supports testicular rather than hypothalamic-pituitary disease, but chromosome analysis is required for definitive diagnosis. JAMA+2JAMAKlinefelter Syndrome | Congenital DefectsScienceDirectKaryotype 47,XXY - an overview | ScienceDirect TopicsWileyClinical and Diagnostic Features of Patients With Suspected Klinefelter Syndrome - Kamischke - 2003 - Journal of Andrology - Wiley Online Library

Confirm the diagnosis with peripheral-blood chromosome analysis demonstrating 47,XXY or a sex-chromosome mosaic pattern such as 46,XY/47,XXY. The usual nonmosaic complement is 47,XXY; mosaicism matters clinically because sperm production is more often observed in 46,XY/47,XXY than in nonmosaic disease. ScienceDirect+1ScienceDirectDetection of low-grade mosaicism and its correlation with hormonal profile, testicular volume, and semen quality in a cohort of Egyptian Klinefelter and Klinefelter-like patients - ScienceDirecturowebMale Infertility - EAU Guidelines on Sexual and Reproductive Health - Uroweb

After cytogenetic confirmation, document symptoms and biochemical severity of androgen deficiency with testosterone, LH, and FSH, and perform a genital examination that includes testicular size and assessment for gynecomastia. Testicular failure may evolve through puberty: inhibin B can be normal before puberty and then decline during late puberty, consistent with progressive seminiferous failure around gonadarche. ScienceDirect+1ScienceDirectKaryotype 47,XXY - an overview | ScienceDirect TopicsScienceDirectKlinefelter Syndrome - an overview | ScienceDirect Topics

Ask specifically about current and future biologic paternity before prescribing testosterone. Obtain semen analysis when feasible because sperm production is variable and is more frequently observed with 46,XY/47,XXY mosaicism. Azoospermia does not end fertility evaluation: testicular sperm retrieval remains an option for selected patients. uroweburowebMale Infertility - EAU Guidelines on Sexual and Reproductive Health - Uroweb

Screen deliberately for metabolic, cardiovascular, diabetic, skeletal, reproductive, and psychological comorbidity rather than limiting follow-up to serum testosterone. Klinefelter syndrome is associated with hypogonadism, infertility, metabolic syndrome, cardiovascular disease, diabetes, osteoporosis, increased mortality risk, psychological burden, and reduced health-related quality of life. Oxford AcademicOxford AcademicUpdate on Physical, Psychological, and Quality of Life Management in Klinefelter Syndrome | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic

Refer azoospermic men with Klinefelter syndrome who desire biologic paternity to a reproductive urologist experienced in TESE or micro-TESE. Testicular sperm can be recovered in up to 50% of azoospermic patients, and residual germ cells or sperm production are more common in 46,XY/47,XXY mosaicism. uroweburowebMale Infertility - EAU Guidelines on Sexual and Reproductive Health - Uroweb

Avoid starting testosterone replacement when TESE is planned, because exogenous testosterone can suppress spermatogenesis; the European Academy of Andrology guideline suggests against beginning testosterone before planned TESE. This is a sequencing issue, not a reason to withhold fertility counseling until androgen-deficiency symptoms become severe. WileyWileyEuropean academy of andrology guidelines on Klinefelter ...

Do not routinely offer surgical fertility preservation to children with Klinefelter syndrome. Evidence summarized for patients younger than 16 years shows lower testicular sperm extraction retrieval rates than in adolescents and adults aged 16 to 30 years; germ-cell retrieval is particularly low before age 15. Oxford AcademicOxford AcademicKlinefelter syndrome and fertility: sperm preservation should not be offered to children with Klinefelter syndrome | Human Reproduction | Oxford Academic

For confirmed Klinefelter syndrome with clinically significant androgen deficiency, testosterone replacement is the central endocrine treatment and is used from puberty to induce and maintain male secondary sexual characteristics. Because the severity and timing of progressive testicular failure vary, individualize initiation and dose rather than applying a uniform age-based regimen. Nature+1NatureKlinefelter Syndrome Clinical Perspectives and TreatmentsScienceDirectKlinefelter Syndrome - an overview | ScienceDirect Topics

Before initiating testosterone, resolve whether TESE is planned. If fertility treatment is not imminent, endocrine treatment should be integrated with monitoring of metabolic, cardiovascular, bone, reproductive, and psychological domains rather than judged only by changes in testosterone concentration or sexual characteristics. Oxford Academic+1Oxford AcademicUpdate on Physical, Psychological, and Quality of Life Management in Klinefelter Syndrome | The Journal of Clinical Endocrinology & Metabolism | Oxford AcademicWileyEuropean academy of andrology guidelines on Klinefelter ...

Do not presume that testosterone corrects every Klinefelter-associated risk. Published management reviews identify disease burden across metabolic, cardiovascular, thrombotic, skeletal, reproductive, neurocognitive, and quality-of-life domains; each requires condition-specific assessment and treatment. Oxford Academic+1Oxford AcademicUpdate on Physical, Psychological, and Quality of Life Management in Klinefelter Syndrome | The Journal of Clinical Endocrinology & Metabolism | Oxford AcademicWileyMorbidity in Klinefelter syndrome and the effect of testosterone treatment

At longitudinal visits, reassess cardiometabolic disease, diabetes risk, cardiovascular disease, bone health, reproductive goals, and quality of life. These domains are repeatedly identified as common comorbidities in Klinefelter syndrome and should remain active problem-list items even when androgen symptoms are controlled. Oxford AcademicOxford AcademicUpdate on Physical, Psychological, and Quality of Life Management in Klinefelter Syndrome | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic

Revisit fertility goals before changing endocrine treatment or when a patient transitions from adolescence to adulthood. The decision to pursue TESE or micro-TESE is preference-sensitive, depends on azoospermia and local procedural expertise, and is particularly relevant before initiating or resuming testosterone therapy. Wiley+1WileyEuropean academy of andrology guidelines on Klinefelter ...urowebMale Infertility - EAU Guidelines on Sexual and Reproductive Health - Uroweb

Screen for psychological burden and functional impairment at each major life transition, including school progression, transfer to adult care, partnership, and infertility evaluation. Reduced health-related quality of life has been reported across physical, psychological, and social domains, so management should include targeted support rather than relying on endocrine correction alone. Oxford AcademicOxford AcademicUpdate on Physical, Psychological, and Quality of Life Management in Klinefelter Syndrome | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic